CC
ORIC icon

Corton Capital’s Oric Pharmaceuticals ORIC Stock Holding History

Corton Capital’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,440
Closed -$179K – 575
2024
Q3 		$179K Sell
17,440
-19,203
-52% -$190K 0.09% 401
2024
Q2 		$259K Buy
+36,643
New +$328K 0.14% 242
2022
Q2 		– Sell
-10,501
Closed -$56K – 465
2022
Q1 		$56K Sell
10,501
-6,411
-38% -$57.7K 0.02% 411
2021
Q4 		$249K Buy
+16,912
New +$264K 0.11% 189

Other funds holding ORIC

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return